Andersen-Tawil syndrome classification: Difference between revisions
Jump to navigation
Jump to search
m Bot: Adding CME Category::Cardiology |
|||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{CP}}; {{RT}} | {{CMG}}; {{AE}} {{CP}}; {{RT}} | ||
== | ==Overview== | ||
Two types of Andersen-Tawil syndrome are distinguished by their genetic causes. | Two types of Andersen-Tawil syndrome are distinguished by their genetic causes. | ||
* Type 1, which accounts for about 60 percent of all cases of the disorder, is caused by mutations in the ''[[KCNJ2]]'' [[gene]]. <ref>{{cite journal|author=Tristani-Firouzi M, Jensen JL, Donaldson MR, ''et al'' |title=Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) |journal=J. Clin. Invest. |volume=110 |issue=3 |pages=381-8 |year=2002 |pmid=12163457 |doi=}}</ref><ref>{{cite journal |author=Pegan S, Arrabit C, Slesinger PA, Choe S |title=Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1|journal=Biochemistry|volume=45 |issue=28 |pages=8599-606 |year=2006 |pmid=16834334 |doi=10.1021/bi060653d}}</ref> | * Type 1, which accounts for about 60 percent of all cases of the disorder, is caused by mutations in the ''[[KCNJ2]]'' [[gene]]. <ref>{{cite journal|author=Tristani-Firouzi M, Jensen JL, Donaldson MR, ''et al'' |title=Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome) |journal=J. Clin. Invest. |volume=110 |issue=3 |pages=381-8 |year=2002 |pmid=12163457 |doi=}}</ref><ref>{{cite journal |author=Pegan S, Arrabit C, Slesinger PA, Choe S |title=Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1|journal=Biochemistry|volume=45 |issue=28 |pages=8599-606 |year=2006 |pmid=16834334 |doi=10.1021/bi060653d}}</ref> | ||
* The remaining 40 percent of cases are designated as type 2; the cause of the condition in these cases is unknown. | * The remaining 40 percent of cases are designated as type 2; the cause of the condition in these cases is unknown. | ||
== Classification == | |||
There is no established system for the classification of [disease name]. | |||
OR | |||
[Disease name] may be classified according to [classification method] into [number] subtypes/groups: | |||
* [Group1] | |||
* [Group2] | |||
* [Group3] | |||
* [Group4] | |||
OR | |||
[Disease name] may be classified into [large number > 6] subtypes based on: | |||
* [Classification method 1] | |||
* [Classification method 2] | |||
* [Classification method 3] | |||
[Disease name] may be classified into several subtypes based on: | |||
* [Classification method 1] | |||
* [Classification method 2] | |||
* [Classification method 3] | |||
==References== | ==References== | ||
Revision as of 21:01, 27 January 2020
|
Andersen-Tawil syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Andersen-Tawil syndrome classification On the Web |
|
American Roentgen Ray Society Images of Andersen-Tawil syndrome classification |
|
Risk calculators and risk factors for Andersen-Tawil syndrome classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Charmaine Patel, M.D. [2]; Raviteja Guddeti, M.B.B.S. [3]
Overview
Two types of Andersen-Tawil syndrome are distinguished by their genetic causes.
- Type 1, which accounts for about 60 percent of all cases of the disorder, is caused by mutations in the KCNJ2 gene. [1][2]
- The remaining 40 percent of cases are designated as type 2; the cause of the condition in these cases is unknown.
Classification
There is no established system for the classification of [disease name].
OR
[Disease name] may be classified according to [classification method] into [number] subtypes/groups:
- [Group1]
- [Group2]
- [Group3]
- [Group4]
OR
[Disease name] may be classified into [large number > 6] subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
[Disease name] may be classified into several subtypes based on:
- [Classification method 1]
- [Classification method 2]
- [Classification method 3]
References
- ↑ Tristani-Firouzi M, Jensen JL, Donaldson MR; et al. (2002). "Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)". J. Clin. Invest. 110 (3): 381–8. PMID 12163457.
- ↑ Pegan S, Arrabit C, Slesinger PA, Choe S (2006). "Andersen's syndrome mutation effects on the structure and assembly of the cytoplasmic domains of Kir2.1". Biochemistry. 45 (28): 8599–606. doi:10.1021/bi060653d. PMID 16834334.